Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses

Virus Research

Volumn 79, Issue 1-2, 2001, Pages 1-14

  Caufour, P S ^a   Motta, M C A ^a   Yamamura, A M Y ^b   Vazquez, S ^a,c   Ferreira, I ^b   Jabor, A V ^a   Bonaldo, M C ^a   Freire, M S ^b   Galler, R ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Instituto de Tecnologia em Imunobiologicos   (Brazil)

^c INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

Author keywords

Dengue vaccine; Immunogenicity; YF 17D virus recombinants

Indexed keywords

DENGUE VACCINE; UNINDEXED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CHIMERA; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DENGUE VIRUS 2; DIPLOIDY; FIBROBLAST; GENE FUSION; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; INOCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VERO CELL; VIROGENESIS; VIRUS GENE; VIRUS REPLICATION; VIRUS VIRULENCE; YELLOW FEVER FLAVIVIRUS;

AMINO ACID SEQUENCE; ANIMALS; CERCOPITHECUS AETHIOPS; DENGUE VIRUS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MICE; MOLECULAR SEQUENCE DATA; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; VERO CELLS; VIRAL PROTEINS; YELLOW FEVER VIRUS;

FLAVIVIRUS;

EID: 0035813032     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(01)00273-8     Document Type: Article

References (38)

1. NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: In vitro and in vivo studies
2. Japanese encephalitis and dengue vaccines
3. Live attenuated tetravalent dengue vaccine
4. Infectious transcripts and cDNA clones of RNA viruses
5. Construction of intertypic chimeric dengue viruses by substitution of structural protein genes
6. Flavivirus genome organization, expression and evolution
7. Yellow fever/Japanese encephalitis chimeric viruses: Construction and biological properties
8. An unusually high divalent cation requirement for attachment of West Nile virus to primary chick embryo cells
9. The Yellow Fever 17D vaccine virus: Molecular basis of viral attenuation and its use as an expression vector
10. Partial nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue virus type 2, New Guinea C and PUO-218 strains
11. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates
12. Nucleotide sequence of dengue 2 RNA and comparison of encoded proteins with those of other flaviviruses
13. Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterologous association with protein prM
14. Chimeric dengue type 2 (vaccine strain PDK-53)/ dengue type 1 virus as potential candidate dengue type 1 virus vaccine
15. Sequence analysis of cloned dengue virus type 2 genome (New Guinea-C strain)
16. A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice
17. Phylogenetic relationships of dengue-2 viruses
18. Mutagenesis of the signal sequence of yellow fever virus prM protein: Enhancement of signalase cleavage in vitro is lethal for virus production
19. Dengue virus structural differences that correlate with pathogenesis
20. Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3
21. Yellow fever
22. Flaviviruses
23. Accelerated development of vaccines
24. Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses
25. Glycosylation and secretion of yellow fever virus nonstructural protein NS1
26. Heterogeneity in envelope protein sequence and N-linked glycosylation among yellow fever virus vaccine strains
27. A simple method for estimating fifty percent endpoints
28. Nucleotide sequence of yellow fever virus: Implications for flavivirus gene expression and evolution
29. Transcription of infectious yellow fever virus RNA from full-length cDNA templates produced by in vitro ligation
30. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas
31. Nucleotide sequence of classical swine fever virus strain Alfort/187 and transcription of infectious RNA from stably cloned full-length cDNA
32. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by hemagglutination inhibition, neutralization and immune precipitation of the envelope protein
33. Site-specific mutagenesis using the polymerase chain reaction
34. Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine
35. Signal peptidase cleavage at the flavivirus C-prM junction: Dependence on the viral NS2B-3 protease for efficient processing requires determinants in C, the signal peptide and prM
36. Chimeric yellow fever/dengue virus as a candidate dengue vaccine: Quantitation of the dengue virus-specific CD8 T-cell response
37. Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever
38. Upregulation of signalase processing and induction of prM/E secretion by the flavivirus NS2B-3 protease: Roles of protease components